Infant Feeding and Associated Accessories
Auftraggeber: SUPPLY CHAIN COORDINATION LIMITED
42.980.277 £
Offen
Angebotsfrist: 13. Jan. 2027, 15:00 UTC
| Status | Offen |
|---|---|
| Geschätzter Wert | 96.630.000 £ |
| Angebotsfrist | 19. Jan. 2027, 15:00 UTC |
| Veröffentlicht | 18. Nov. 2026 |
| Auftraggeber | SUPPLY CHAIN COORDINATION LIMITED |
| Land | Vereinigtes Königreich · London |
| CPV-Code | 33140000, 18315000, 18300000, 18317000, 35113460 |
| Quelle | Find a Tender ↗ |
Geprüft:
Die amtliche Bekanntmachung ist maßgeblich. Status und Bedingungen können sich nach der Erfassung ändern.
NHS Supply Chain seeks to establish a framework agreement for the supply of Vascular Therapy and Associated Products.
The framework will provide a range of products for acute and chronic vascular therapy requirements and is divided into two Lots:
Lot 1: Acute Therapy Products
Lot 2: Chronic Therapy Products
Tenderers may tender for one or both Lots.
The framework will support NHS Supply Chain and its customers through applicable routes of supply, including Stocked, eDirect and Direct routes, as further described in the procurement documents.
The framework will be available for use by NHS Trusts, other NHS entities, government departments, agencies and other statutory bodies, including local authorities, and private sector entities active in the UK healthcare sector, in accordance with the procurement documents.
The anticipated value of the Framework Agreement for the initial twenty-four (24) month term is approximately £46,230,000 excluding VAT. The Authority may extend the Framework Agreement by up to two further periods of twelve (12) months each. The anticipated total value over the maximum forty-eight (48) month term, including the extension options, is approximately £96,630,000 excluding VAT.
These values are estimates based on historical usage and forecast demand and do not constitute a guarantee of expenditure or business under the Framework Agreement.
Supply of vascular therapy products for acute therapy requirements, as further described within the Specification and associated procurement documents.
82.135.500 £
Supply of vascular therapy products for chronic therapy requirements, as further described within the Specification and associated procurement documents.
14.494.500 £